Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc. Explore Leadership Learn more about our executive leadership team Corporate Governance Policies and processes for how our company is managed...
As a global pharmaceutical company with a rich heritage and a commitment to excellence, we offer a dynamic and inclusive work environment where employees are empowered to make a difference. Join us in our pursuit of better health for people everywhere.As a global pharmaceutical company with a ric...
Life at Takeda Pharmaceutical Learn more Learn more Learn more Dev Guide (New) Learn more Healthcare for all Learn more How We Partner Learn more Innovators in Science Award Winners Learn more Luck is not a strategy Learn more Takeda Unveils Newly Renovated Cambridge Building Learn ...
Takeda Pharmaceutical Company Takeda Pharmaceutical Company Limited Public (TYO: 4502)Founded1781HeadquartersOsaka, JapanKey peopleKunio Takeda,
Discovery Company profile page for Takeda Pharmaceutical Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol
Danzen information about active ingredients, pharmaceutical forms and doses by Takeda Pharmaceutical, Danzen indications, usages and related health products lists
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today obtained the New Drug Application approval for Copaxone® Subcutaneous Injection 20 mg Syringe (generic name: glatiramer acetate), a drug for the treatment of multiple sclerosis, from the Japanese Ministry of ...
Assignee: Takeda Pharmaceutical Company Limited International Classes: C07D413/14; A61P25/28; C07D413/10 Field of Search: 514/364 View Patent Images: Download PDF 11958845 US Patent References: 20230023761 N/A 2023-01-26 Jin et al. 20230021554 N/A 2023-01-26 Jin et al. 20220363651 N/...
The cell death inhibitor comprising a substance capable of binding to macrophage migration inhibitory factor is useful as a preventive/therapeutic agent for, e.g., heart diseases, n